Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02180425 · ClinicalTrials.gov registry record
The Lipid Profile of the Skin Surface in Acne
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 30
- Enrollment target
NCT02180425: Completed study, sponsored by University of California, Davis.
NCT02180425 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02180425 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the differences in the skin lipid profile of patients with and without acne. Secondly, the goal is to learn more about what the effects of retinoinds (topical and systemic) are on the the skin lipid profile. We hypothesize that the skin lipid profile of subjects with acne will be lower in inflammatory lipids in comparison to subjects without acne.
Primary Outcome
Compare the skin lipid profile of acne and healthy patients at baseline
Interventions
- DRUG Isotretinoin
- DRUG Tretinoin or Adapalene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-11 |
| Est. Completion | 2015-07 |
What the finished NCT02180425 record still lists
NCT02180425 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Isotretinoin is the first listed.
NCT02180425 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02180425 about?
NCT02180425 is a clinical study titled "The Lipid Profile of the Skin Surface in Acne". The purpose of this study is to evaluate the differences in the skin lipid profile of patients with and without acne. Secondly, the goal is to learn more about what the effects of retinoinds (topical and systemic) are on the the skin lipid profile. We hypothesize that the skin lipid profile of subje...
What is the current status of trial NCT02180425?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2013-11. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02180425?
The interventions under investigation include: Isotretinoin (DRUG), Tretinoin or Adapalene (DRUG).
Who is sponsoring clinical trial NCT02180425?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia